Clinical trial
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
NCT07360314
Study timeline
Study start (actual)2026-02-13Date precision: day
Registry last updated2026-09-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Solid Tumorsunresolved
Interventions
Sponsors & collaborators
Merck KGaA, Darmstadt, Germanycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07360314 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.